To further substantiate the influences of KIF13B on MAFLD via AMPKα1, our in vivo experiments furnished additional evidence, demonstrating that elevated KIF13B expression effectively alleviated MASH pathogenesis induced by an MCD. Here, KIF13B is linked to metabolic dysfunction-associated steatohepatitis.